About this trial
To establish the reference range of the NTproBNP2 Test Kit (time-resolved immunofluorescence method) in apparently healthy Chinese population.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Voluntarily participate in this study and sign informed consent;
Body Mass Index (BMI) ≥18.5 and <28kg/ m2;
Age ≥18 years old;
Through the investigator's consultation with the subjects, evaluate the subjects who meet the requirements of the reference individual of this study (refer to the "reference individual questionnaire").
Disqualifiers
eGFR(estimated glomerular filtration rate) (formula: CKD-EPI, chronic kidney disease epidemiology collaboration) < 60 mL/min/1.732
Systolic blood pressure ≥130 mm Hg and/or diastolic blood pressure ≥80 mmHg
Glycated hemoglobin A1c (HbA1c) ≥ 6.0%; or fasting blood glucose ≥ 7.0 mmol/L
Total cholesterol ≥ 6.22 mmol/L and/or triglycerides ≥ 2.26 mmol/L
Trial population
To establish the reference range of the NTproBNP2 Test Kit (time-resolved immunofluorescence method) in apparently healthy Chinese population.
Trial design
Case-only
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
AQT90 FLEX NTproBNP2 Test Kit - Reference Interval Establishment - China
To establish the reference range of the NTproBNP2 Test Kit (time-resolved immunofluorescence method) in apparently healthy Chinese population.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: